PULMATRIX, INC. Basic Shares Outstanding (Weighted Average)
PULMATRIX, INC. (PULM) reported Basic Shares Outstanding (Weighted Average) of 3.65 million shares for the 3-month period ending 2026-06-30, per its S-4/A filed 2026-09-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-09-17
- PULMATRIX, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 3.65M shares, a 0.00% change year-over-year.
- PULMATRIX, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 3.65M shares, a 0.00% change year-over-year.
- PULMATRIX, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 3.65M shares, a 0.00% change year-over-year.
- PULMATRIX, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 3.65M shares, a 0.00% change year-over-year.
- PULMATRIX, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 3.65M shares, a 99.89% decline from fiscal 2022.
- PULMATRIX, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 3.45B shares, a 127189.17% increase from fiscal 2021.
- PULMATRIX, INC. weighted average number of shares outstanding, basic for fiscal 2021 was 2.71M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.65M shares S-4/A · filed 2026-09-17 | 3.65M shares S-4/A · filed 2026-09-17 | 3.65M shares derived: average of 3 quarters · filed 2026-09-17 | 3.65M shares derived: average of 4 quarters · filed 2026-09-17 | ||||
| 2026-03-31 | 3.65M shares S-4/A · filed 2026-08-03 | 3.65M shares derived: average of 2 quarters · filed 2026-09-17 | 3.65M shares derived: average of 3 quarters · filed 2026-09-17 | 3.65M shares derived: average of 4 quarters · filed 2026-09-17 | ||||
| 2025-12-31 | 3.65M shares derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | 3.65M shares derived: average of 2 quarters · filed 2026-09-17 | 3.65M shares derived: average of 3 quarters · filed 2026-09-17 | 3.65M shares S-4/A · filed 2026-09-17 | ||||
| 2025-09-30 | 3.65M shares 10-Q · filed 2025-10-16 | 3.65M shares derived: average of 2 quarters · filed 2026-09-17 | 3.65M shares 10-Q · filed 2025-10-16 | 3.65M shares derived: average of 4 quarters · filed 2026-09-17 | ||||
| 2025-06-30 | 3.65M shares S-4/A · filed 2026-09-17 | 3.65M shares S-4/A · filed 2026-09-17 | 3.65M shares derived: average of 3 quarters · filed 2026-09-17 | 3.65M shares derived: average of 4 quarters · filed 2026-09-17 | ||||
| 2025-03-31 | 3.65M shares S-4/A · filed 2026-08-03 | 3.65M shares derived: average of 2 quarters · filed 2026-09-17 | 3.65M shares derived: average of 3 quarters · filed 2026-09-17 | 3.65M shares derived: average of 4 quarters · filed 2026-09-17 | ||||
| 2024-12-31 | 3.65M shares derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | 3.65M shares derived: average of 2 quarters · filed 2026-09-17 | 3.65M shares derived: average of 3 quarters · filed 2026-09-17 | 3.65M shares S-4/A · filed 2026-09-17 | ||||
| 2024-09-30 | 3.65M shares 10-Q · filed 2025-10-16 | 3.65M shares derived: average of 2 quarters · filed 2025-10-16 | 3.65M shares 10-Q · filed 2025-10-16 | 3.65M shares derived: average of 4 quarters · filed 2025-10-16 | ||||
| 2024-06-30 | 3.65M shares 10-Q · filed 2025-08-06 | 3.65M shares 10-Q · filed 2025-08-06 | 3.65M shares derived: average of 3 quarters · filed 2025-08-06 | 3.65M shares derived: average of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | 3.65M shares 10-Q · filed 2025-05-15 | 3.65M shares derived: average of 2 quarters · filed 2025-05-15 | 3.65M shares derived: average of 3 quarters · filed 2025-05-15 | 3.65M shares derived: average of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | 3.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | 3.65M shares derived: average of 2 quarters · filed 2025-03-21 | 3.65M shares derived: average of 3 quarters · filed 2025-03-21 | 3.65M shares 10-K · filed 2025-03-21 | 3.65B shares 10-K · filed 2024-03-28 | |||
| 2023-09-30 | 3.65M shares 10-Q · filed 2024-11-08 | 3.65B shares 10-Q · filed 2023-11-09 | 3.65M shares derived: average of 2 quarters · filed 2024-11-08 | 3.65M shares 10-Q · filed 2024-11-08 | 3.65B shares 10-Q · filed 2023-11-09 | 913.06M shares derived: average of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | 3.65M shares 10-Q · filed 2024-08-13 | 3.65B shares 10-Q · filed 2023-08-10 | 3.65M shares 10-Q · filed 2024-08-13 | 3.65B shares 10-Q · filed 2023-08-10 | 1.22B shares derived: average of 3 quarters · filed 2024-08-13 | 1.78B shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 3.65M shares 10-Q · filed 2024-05-10 | 1.82B shares derived: average of 2 quarters · filed 2024-05-10 | 2.37B shares derived: average of 3 quarters · filed 2024-05-10 | 2.62B shares derived: average of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | 3.64B shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 3.56B shares derived: average of 2 quarters · filed 2024-03-28 | 3.50B shares derived: average of 3 quarters · filed 2024-03-28 | 3.45B shares 10-K · filed 2024-03-28 | 3.45M shares 10-K · filed 2023-03-30 | |||
| 2022-09-30 | 3.48B shares 10-Q · filed 2023-11-09 | 3.48M shares 10-Q · filed 2022-11-10 | 3.43B shares derived: average of 2 quarters · filed 2023-11-09 | 3.38B shares 10-Q · filed 2023-11-09 | 3.38M shares 10-Q · filed 2022-11-10 | 1.71B shares derived: average of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | 3.37B shares 10-Q · filed 2023-08-10 | 3.37M shares 10-Q · filed 2022-08-10 | 3.33B shares 10-Q · filed 2023-08-10 | 3.33M shares 10-Q · filed 2022-08-10 | 1.13B shares derived: average of 3 quarters · filed 2023-08-10 | 845.27M shares derived: average of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | 3.30M shares 10-Q · filed 2023-05-12 | 3.08M shares derived: average of 2 quarters · filed 2023-05-12 | 2.99M shares derived: average of 3 quarters · filed 2023-05-12 | 2.95M shares derived: average of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | 2.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 2.84M shares derived: average of 2 quarters · filed 2023-03-30 | 2.83M shares derived: average of 3 quarters · filed 2023-03-30 | 2.71M shares 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 2.81M shares 10-Q · filed 2022-11-10 | 2.81M shares derived: average of 2 quarters · filed 2022-11-10 | 2.65M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 2.81M shares 10-Q · filed 2022-08-10 | 2.57M shares 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |